Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis

References

• Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966; 153: 80–2
   PubMed Web of Science ®Google Scholar
• David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966; 56: 72–7
   PubMed Web of Science ®Google Scholar
• Bucala R. MIF re-discovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 1996; 7: 19–24
   Google Scholar
• Donn RP, Shelley E, Ollier WE, Thompson W. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782–5
   PubMedGoogle Scholar
• Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2402–9
   PubMed Web of Science ®Google Scholar
• Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895–902
   PubMed Web of Science ®Google Scholar
• Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 1997; 150: 235–46
   PubMed Web of Science ®Google Scholar
• Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756–9
   PubMed Web of Science ®Google Scholar
• Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996; 93: 7849–54
   PubMed Web of Science ®Google Scholar
• Nishihira J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J Interferon Cytokine Res 2000; 20: 751–62
   PubMed Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417–29
   PubMed Web of Science ®Google Scholar
• Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterology 1997; 92: 5S–11S
   PubMed Web of Science ®Google Scholar
• Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 2000; 51: 289–98
   PubMed Web of Science ®Google Scholar
• de Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2: 1061–6
   PubMed Web of Science ®Google Scholar
• Ohkawara T, Nishihira J, Takeda H, Hige S, Kato M, Sugiyama T, et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002; 123: 256–70
   PubMed Web of Science ®Google Scholar
• Murakami H, Akbar SM, Matsui H, Onji M. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001; 31: 337–43
   PubMed Web of Science ®Google Scholar
• Ohkawara T, Miyashita K, Nishihira J, Mitsuyama K, Takeda H, Kato M, et al. Transgenic overexpression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis. Clin Exp Immunol 2005; 140: 241–8
   PubMed Web of Science ®Google Scholar
• Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344–67
   PubMed Web of Science ®Google Scholar
• Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694–702
   PubMed Web of Science ®Google Scholar
• Honma N, Koseki H, Akasaka T, Nakayama T, Taniguchi M, Serizawa I, et al. Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 2000; 100: 84–90
   PubMed Web of Science ®Google Scholar
• Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238–49
   PubMed Web of Science ®Google Scholar
• Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189: 341–6
   PubMed Web of Science ®Google Scholar
• Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320–3
   PubMed Web of Science ®Google Scholar
• Onodera S, Kaneda K., Mizue Y., Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000; 275: 444–50
   PubMed Web of Science ®Google Scholar
• Shimizu T, Abe R, Ohkawara A, Nishihira J. Ultraviolet B radiation up-regulates the production of macrophage migration inhibitory factor (MIF) in human epidermal keratinocytes. J Invest Dermatol 1999; 112: 210–5
   PubMedGoogle Scholar
• Fukuzawa J, Nishihira J, Hasebe N, Haneda T, Osaki J, Saito T, et al. Contribution of macrophage migration inhibitory factor to extracellular signal-regulated kinase activation by oxidative stress in cardiomyocytes. J Biol Chem 2002; 277: 24889–95
   PubMedGoogle Scholar
• Ohkawara T, Nishihira J, Ishiguro Y, Otsubo E, Nagai K, Takeda H, et al. Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice. Immunol Lett 2006; 107: 148–54
   PubMedGoogle Scholar
• Makita H, Nishimura M, Miyamoto K, Nakano T, Tanino Y, Hirokawa J, et al. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 1998; 158: 573–9
   PubMed Web of Science ®Google Scholar
• Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344–50
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Nishihira J, Watanabe S, Todo S. Prevention of lethal acute hepatic failure by anti-macrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide. Hepatology 1999; 29: 1752–9
   PubMedGoogle Scholar
• Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107: 1643–52
   PubMed Web of Science ®Google Scholar
• Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003; 199: 28–35
   PubMed Web of Science ®Google Scholar
• Gijsbers K, Van Assche G, Joossens S, Struyf S, Proost P, Rutgeerts P, et al. CXCR1-binding chemokines in inflammatory bowel diseases: down-regulated IL-8/CXCL8 production by leukocytes in Crohn's disease and selective GCP/CXCL6 expression in inflamed intestinal tissue. Eur J Immunol 2004; 34: 1992–2000
   PubMedGoogle Scholar
• Reinecker HC, Loh EY, Ringer DJ, Mehta A, Rombeau JL, MacDermott RP, et al. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995; 108: 40–50
   PubMed Web of Science ®Google Scholar
• MacDermott RP, Sanderson IR, Reinecker HC. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998; 4: 54–67
   PubMed Web of Science ®Google Scholar
• McCormack G, Moriarty D, O'Donoghue DP, McCormick PA, Sheahan K, Baird AW. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm Res 2001; 50: 491–5
   PubMed Web of Science ®Google Scholar
• Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, et al. Increased expression of IP-10, IL-8, MCP-1, MCP-3 in ulcerative colitis. Am J Pathol 1999; 155: 331–6
   PubMed Web of Science ®Google Scholar
• Sasaki S, Yoneyama H, Suzuki K, Suriki H, Aiba T, Watanabe S, et al. Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol 2002; 32: 3197–205
   PubMed Web of Science ®Google Scholar
• Singh UP, Singh S, Taub DD, Lillard JW, Jr. Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10−/ −  mice. J Immunol 2003; 171: 1401–6
   PubMed Web of Science ®Google Scholar
• Ohtsuka Y, Sanderson IR. Dextran sulfate sodium-induced inflammation is enhanced by intestinal epithelial cell chemokine expression in mice. Pediatr Res 2003; 53: 143–7
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989; 169: 1449–59
   PubMed Web of Science ®Google Scholar
• Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485–90
   PubMed Web of Science ®Google Scholar
• Allavena P, Bianchi G, Zhou D, van Damme J, Jilek P, Sozzani S, et al. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol 1994; 24: 3233–6
   PubMed Web of Science ®Google Scholar
• Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994; 91: 3652–6
   PubMed Web of Science ®Google Scholar
• Andres PG, Beck PL, Mizoguchi E, Bhan AK, Dawson T, Kuziel WA, et al. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK 1.1+ lymphocyte-associated Th-2-type immune response in the intestine. J Immunol 2000; 164: 6303–12
   PubMed Web of Science ®Google Scholar
• Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H, et al. Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Arthritis Rheum 2004; 50: 1437–47
   PubMed Web of Science ®Google Scholar
• Ichiyama H, Onodera S, Nishihira J, Ishibashi T, Nakayama T, Minami A, et al. Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 2004; 26: 187–94
   PubMed Web of Science ®Google Scholar
• Tanino Y, Makita H, Miyamoto K, Betsuyaku T, Ohtsuka Y, Nishihira J, et al. Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002; 283: L156–62
   Google Scholar